A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.
Oct 1, 2018
0
12
Drug shortages and price hikes have become a critical issue in the health care industry. A recent example of this occurred when a shortage of intravenous fluids and injectable opioids ensued due to manufacturing delays in ...
Aug 9, 2018
0
0
Anticancer drug costs in the United States increase substantially after launch regardless of competition, according to a new study just published in the Journal of Clinical Oncology.
Oct 31, 2017
0
5
If the cost of your generic prescription drug has risen, it may be due to a lack of competition among drug manufacturers, according to a University of Florida College of Pharmacy study.
Jul 3, 2017
0
2
Leading drug researcher Associate Professor Chris Wilkins from Massey University's SHORE and Whāriki Research Centre is calling for the adoption of a not-for-profit public health model for recreational cannabis. It would ...
Jun 21, 2017
0
12
A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found that physicians in academic medical centers (AMCs) prescribed fewer of the promoted drugs, and more non-promoted ...
May 2, 2017
0
0
(HealthDay)—Extending the market exclusivity for existing drugs that are granted subsequent U.S. Food and Drug Administration (FDA) approval for a new rare disease indication would provide manufacturers with substantial ...
Jan 23, 2017
0
0
(HealthDay)—The U.S. Food and Drug Administration has suggested setting a limit on how much lead can be in cosmetics ranging from lipstick and eye shadow to blush and shampoo.
Dec 23, 2016
0
0
The rising price for EpiPens, a drug delivery system that is crucial for persons experiencing potentially life-threatening allergic reactions, has resulted in outrage. The price increase, from about US$94 for a two-pack of ...
Aug 25, 2016
0
1
High prescription drug prices are attributable to several causes, including the approach the U.S. has taken to granting government-protected monopolies to drug manufacturers, and the restriction of price negotiation at a ...
Aug 23, 2016
0
0
